Adagio Medical Presents Preliminary Results from FULCRUM-VT Study, Showing High Acute Success Rate in Treating Ventricular Tachycardia.

Adagio Medical has presented preliminary results from its FULCRUM-VT study, evaluating Ultralow Temperature Cryoablation for treating Sustained Monomorphic Ventricular Tachycardia. The study included 207 patients with both ischemic and non-ischemic cardiomyopathy, with 97.4% achieving acute clinical success and a 2.5% major adverse events rate. The results suggest a promising tool for treating VT, a largely undertreated condition.